ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,155, issued on Oct. 7, was assigned to MACROGENICS INC. (Rockville, Md.).
"CD137 binding molecules and uses thereof" was invented by Alexey Yevgenyevich Berezhnoy (Rockville, Md.), Gundo Diedrich (Rockville, Md.), Paul A. Moore (Rockville, Md.), Ezio Bonvini (Rockville, Md.) and Kalpana Shah (Rockville, Md.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is directed to binding molecules that possess one or more epitope-binding sites specific for an epitope of CD137, including antibodies, and molecules comprising epitope-binding fragments thereof. The invention is further directed to multispecific binding molecules comprising one ...